Literature DB >> 28685764

Market watch: Strategies for biosimilars in emerging markets.

Ajay Gautam.   

Abstract

Year:  2017        PMID： 28685764     DOI： 10.1038/nrd.2017.113

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  4 in total

Review 1.  Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.

Authors:  Timothy M Pierpont; Candice B Limper; Kristy L Richards
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

2.  Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study.

Authors:  Hasumati Rahalkar; Alan Sheppard; Carlos Augusto Lopez-Morales; Luciano Lobo; Sam Salek
Journal:  Pharmaceut Med       Date:  2021-07-22

Review 3.  Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.

Authors:  Ross A McKinnon; Matthew Cook; Winston Liauw; Mona Marabani; Ian C Marschner; Nicolle H Packer; Johannes B Prins
Journal:  BioDrugs       Date:  2018-02       Impact factor: 5.807

Review 4.  Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines.

Authors:  Hasumati Rahalkar; Hacer Coskun Cetintas; Sam Salek
Journal:  Front Pharmacol       Date:  2018-09-28       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.